North America Prefilled Syringes Market worth $4.83 billion by 2030
The report "North America Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled, Plastic), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), and Country - Forecast to 2030", is projected to reach USD 4.83 billion by 2030 from USD 2.87 billion in 2025, at a CAGR of 11.0% during the forecast period.
Browse 150 market data Tables and 60 Figures spread through 200 Pages and in-depth TOC on "North America Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled, Plastic), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), and Country - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-prefilled-syringes-market-143362172.html
The growth of the North America prefilled syringes market is primarily driven by the rising prevalence of chronic diseases requiring long-term therapies, the growing global elderly population, and the increasing adoption of biological drugs, which often require precise dosing and administration. However, stringent approval regulations and safety issues associated with prefilled syringes can affect market growth, requiring continuous innovation and rigorous testing to overcome these barriers.
By type, the conventional prefilled syringes segment is expected to account for the largest share in the North America prefilled syringes market during the forecast period.
The conventional prefilled syringe segment holds the largest share of the North America prefilled syringes market due to its widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment's dominance is driven by its versatility and the established manufacturing processes that support large-scale production to meet global healthcare demands effectively. Conventional prefilled syringes contribute a significant share of the overall prefilled syringe segment because they are widely used in various therapeutic applications. These syringes come pre-filled with a specific dosage of medication, ensuring ease of use and accurate dosing for healthcare providers as well as patients. They are user-friendly, have a reduced risk of contamination, and are compatible with a variety of drugs. The versatility of this segment complements established manufacturing methods in large-scale production to ensure adequate supply to global healthcare needs.
The glass prefilled syringes segment is expected to account for the largest share, by material, during the forecast period.
The glass prefilled syringes segment holds the largest share of the North America prefilled syringes market, primarily because of its superior material properties and suitability for sensitive drug formulations. Generally, glass syringes possess a few inherent advantages because they are inert; thus, the risk of drug interaction or leaching is very low. They are thus ideal for biologics, vaccines, and other complex formulations. In addition, glass syringes are transparent, allowing the drug to be visible, which is helpful for accurate dosage administration. Glass syringes are not as durable as plastic ones, but advances in glass technology have resulted in glass syringes that are safer and more robust, thus continuing the dominance of glass syringes in the market.
The single-chamber prefilled syringes segment is expected to account for the largest share by design during the forecast period.
The single-chamber prefilled syringe segment commands the highest share in the North America prefilled syringes market because of its design simplicity, cost-effectiveness, and efficiency in drug delivery. The syringe consists of a single compartment that is prefilled with a specific drug, making it easy to manufacture and use. To minimize drug errors and allow easier handling, these syringes are widely used across a number of therapeutic fields, ranging from vaccines to insulin.
The cancer segment is expected to account for the largest share by application in the North America prefilled syringes market during the forecast period.
The cancer segment holds the largest share of the North America prefilled syringes market, driven by rising prevalence and demand for precise, targeted drug delivery systems. Key advantages of prefilled syringes in oncology include accurate dosing, reduced contamination risk, and improved patient compliance. They can deliver chemotherapeutics, monoclonal antibodies, and supportive care drugs, enabling tailored therapies and better patient outcomes. This segment's performance underscores the indispensable role of prefilled syringes in advanced cancer treatments and ongoing innovations aimed at addressing specific oncological conditions.
In 2024, US accounted for the largest share of the North America prefilled syringes market.
The North America prefilled syringes market is segmented into the US and Canada. The US holds the highest share in the North America prefilled syringes market due to advanced healthcare infrastructure, high adoption of advanced medical technologies, and extensive investments in drug development and research. The North American position is further supported by strict regulatory standards that endorse the use of prefilled syringes for effective and safe drug delivery. In addition, rising chronic disease prevalence is increasing demand for prefilled syringes in the US. Furthermore, the presence of numerous pharmaceutical companies and biotechnology firms enhances market growth, giving the region a strong foothold in this market.
Key Market Players:
The key players in the North America prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Medical International Co., Ltd. (China), Credence MedSystems, Inc. (US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymed (India), MedXL, Inc. (Canada), and Sharps Technology, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the North America Prefilled Syringes Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
